![Rank: 8](static/image/common/star_level3.gif) ![Rank: 8](static/image/common/star_level3.gif)
- 现金
- 62111 元
- 精华
- 26
- 帖子
- 30437
- 注册时间
- 2009-10-5
- 最后登录
- 2022-12-28
|
| TLR7 agonist RO7020531 triggers immune activation after
multiple doses in chronic hepatitis B patients
|
|
| Reported by Jules Levin
AASLD 2018 Nov 9-13 SF
Edward J. Gane1, KoshAgarwal2, Rosalina Balabanska3, YonghongZhu4, Lu Gao4, Joseph F. Grippo5 , YuyanJin4, Miriam Triyatni6, Ilia Folitar7, RuchiUpmanyu8, Katerina Glavini6, EoinCoakley9, Tomas Racek6, Man-Fung Yuen10
1. Auckland Clinical Studies; 2. Institute of Liver Studies, Kings College Hospital, London; 3. AcibademCity Clinic, TokudaHospital, Sofia; 4. Roche Innovation Center Shanghai 5. Roche Innovation Center New York; 6. Roche Innovation Center Basel; 7. Roche Innovation Center Basel (former employee); 8. Roche Products Ltd; 9. Roche Innovation Center New York (former employee); 10. Queen Mary Hospital, Hong Kong![](http://natap.org/2018/images%20/112018/112019-3/1120181.gif)
![](http://natap.org/2018/images%20/112018/112019-3/1120182.gif)
![](http://natap.org/2018/images%20/112018/112019-3/1120183.gif)
![](http://natap.org/2018/images%20/112018/112019-3/1120184.gif)
![](http://natap.org/2018/images%20/112018/112019-3/1120185.gif)
|
|
| ![](http://natap.org/2018/AASLD/images/null.gif) | ![](http://natap.org/2018/AASLD/images/null.gif) |
|
-
总评分: 现金 + 20
查看全部评分
|